Author

Eloïse Marques

Hôpital Necker-Enfants MaladesORCID 0000-0001-9658-3199Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:development & morphogenesis· 1 Assay:imaging· 1 Assay:metabolomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Alex von KriegsheimiD· 1 shared Alva M. CaseyiD· 1 shared Aniela Zablocki· 1 shared Arthur KaseriD· 1 shared Chak Shun YuiD· 1 shared Christopher A. PowelliD· 1 shared Clare Elizabeth BryantiD· 1 shared Clément Nguyen· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Alex von KriegsheimORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

An inherited mtDNA mutation remodels inflammatory cytokine responses in macrophages and in vivo

Eloïse Marques, Stephen P. Burr, Alva M. Casey, Richard J Stopforth, Chak Shun Yu, Keira Turner, Dane M. Wolf, Marisa Dilucca, Victoria J. Tyrrell, Robbin Kramer, Yamini M Kanse, Christopher A. Powell, James Bruce Stewart, Michael P. Murphy, Michal A. Minczuk, , Dylan G. Ryan

This study shows that an inherited mtDNA mutation alters inflammatory cytokine responses in macrophages and in vivo, leading to increased IFN-I and reduced pro-inflammatory cytokines.

bioRxiv · Jan 5, 2025 · PreprintImmunology

Lcn2 protects from cisplatin induced AKI by regulating DNA damage response via EGFR activation

Aniela Zablocki, Eloïse Marques, Lucie Yammine, Clément Nguyen, Fabiola Terzi, Morgan Gallazzini

This study shows Lcn2 protects kidneys from cisplatin-induced AKI by activating the EGFR pathway to reduce apoptosis.

bioRxiv · May 3, 2024 · PreprintCell Biology